16.88 USD
▲0.00+0.06%
盘后 16.87 +0.06%
2026-08-03
市值
$874.86M
市盈率
7.63
EPS
2.21
股息率
—
52 周区间
10.82 – 21.03
成交量
420.21K
Beta
0.17
目标价
17.67
52W 低 10.8252W 高 21.03
价格走势
公司简介
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. fo...